Investment enables Resilient Medical to lease and build out lab space, navigate the regulatory approval process, and better position its Bravo™ device for rapid market entry.
TechGrowth Ohio welcomes Max Stoeckel, who has joined client company OsteoDx as Associate Engineer.
The technology-defining pilot project of TechGrowth Ohio client Ohio360 was selected to receive the 2023 Science and Innovation Award for their Appalachian Law Enforcement Initiative project (ALEI).
Along with additional TechGROWTH Fund investment, the company has submitted for a Phase IIB SBIR Grant and received favorable initial scoring.
“We believe Bravo™ will tremendously improve the total healing process for breast cancer patients.”
The Small Business Development Center (SBDC) at Ohio University received top honors for ‘Overall Performance by a Center’ for 2022, measured among the 28 SBDC Centers throughout the State of Ohio.
The National Association of Development Organizations (NADO) has recognized TechGROWTH Ohio with its 2022 Aliceann Wohlbruck NADO Impact Award.
Celebrating Women Entrepreneurship Week, TechGrowth Ohio is partnering with the Center for Entrepreneurship to host an informal, town hall-style Founders Forum with Claire Coder, founder of Aunt Flow. Our event is designed to give entrepreneurs from all over Southeast Ohio a comfortable opportunity to have sticky conversations and share key learnings with each other. [...]
Announcing a new opportunity for technology innovation in Ohio October cohorts are forming now for an exciting new opportunity focused on helping entrepreneurs transform technology innovations into growing businesses. The Ohio SBIR Technology Acceleration Program (TAP) is designed as a week-long program that demystifies the SBIR process for eligible small businesses. It offers free [...]
New Technology May More Accurately Assess Bone Health August 29, 2022 – Last week, Athens, OH-based OsteoDx installed their CBMT™ devices in research facilities at the University of South Florida’s Morasani College of Medicine and the University of Florida College of Medicine to begin patient research studies. OsteoDx has two other research studies in partnership [...]
